$ 776,612 USD
$ 14,000 USD
Our team at The Mueller Health Foundation would like to start by expressing our most heartfelt gratitude to the entire TB community as well as our partners and collaborators for the tremendous amount of work that has been completed over the past 12 months. We are so grateful for the commitment and resilience of all of those fighting to make a difference in TB and for showing unwavering perseverance even during the difficult times of the continuing global COVID-19 pandemic.
The COVID-19 pandemic has unfortunately had a very negative impact on TB funding, research, diagnostics, and treatment options. Furthermore, there has been a significant increase in TB deaths across the globe with more than 4100 people dying every day, which includes 650 children, according to the WHO. To further exacerbate the problem, the WHO states that only 5.8 million people were diagnosed and treated with TB in 2020, down from 7.1 million in 2019. A ray of hope was provided by the TB community’s response in 2021 by deploying new digital X-ray units, using Artificial Intelligence (AI) in improving research, and implementing mobile diagnostics for TB to meet the increasing diagnostic and treatment needs of those affected by TB.
Nonetheless, despite these advancements, the overall progress towards eradicating TB has been set back by over a decade and it is now more important than ever to continue investing time and resources in finding novel preventative and treatment options, particularly for resistant strains of TB. Multidrug-resistant TB (MDR-TB) as well as extensively Drug Resistant TB (XDR-TB) are on the rise and continue to remain a public health crisis.
In an effort to support the fight against infectious diseases and to prevent more global pandemics, The Mueller Health Foundation is committed to continue to help foster and support innovative research that can lead to new treatment options, particularly for the treatment of tuberculosis and resistant strains of TB. Our total committed funds at The Mueller Health Foundation comprise about 4% of grants made by private philanthropies around the globe in 2021.
We hope that the new year will provide many opportunities to advocate for more funding and to make many more tools and improved treatment options available to all of those affected by TB. We thank the TB community for continuing to believe in this cause and encourage everyone to actively join the fight against TB around the globe in 2022!
Prof. Dr. Peter Mueller
Founder and President
The Mueller Health Foundation
Distributed in New Grant Funds in 2021
Committed Through 2024
MHF Committed Funds comprise 4% of the global funds committed by private philanthropies in 2021 to Tuberculosis.
$ 776,612 USD
$ 14,000 USD